Suppr超能文献

美国食品和药物管理局认定人群中美国牙科汞合金修复体的使用比例下降:2017-2023 年。

Declining US dental amalgam restorations in US Food and Drug Administration-identified populations: 2017-2023.

出版信息

J Am Dent Assoc. 2024 Oct;155(10):816-824. doi: 10.1016/j.adaj.2024.07.015. Epub 2024 Sep 7.

Abstract

BACKGROUND

In light of the Minamata Convention on Mercury and efforts to phase down dental amalgam use, tracking dental amalgam proportions across US Food and Drug Administration (FDA)-identified at-risk populations is of interest to optimize material selection aligned with patient needs.

METHODS

A retrospective observational study of Epic's Cosmos electronic health records data set was conducted to calculate the rates of dental amalgam restorations from 2017 through 2023 and stratified using the social vulnerability index (quartile 4 indicates the highest social vulnerability and quartile 1 indicates the lowest) and payer type (Medicare, Medicaid, self-pay, miscellaneous or other). The authors included the following FDA-identified at-risk populations: pregnant people, children younger than 6 years, people with preexisting neurologic conditions, and people with impaired kidney function (n = 1,897,976).

RESULTS

The overall rate of dental amalgam restoration placements in the general population declined from 21.8% in 2017 to 4.1% in 2023. Dental amalgam restoration trends, according to social vulnerability index quartile and payer type, decreased consistently across all 4 evaluated populations. Of all the social vulnerability index quartiles, quartile 4, representing the most socially vulnerable group, had the smallest decrease in dental amalgam placement rates among the FDA-identified populations examined.

CONCLUSIONS

The study results showed a decreasing trend in dental amalgam restorations from 2017 through 2023 among FDA-identified populations, consistent with the Minamata Convention on Mercury directive for a phasedown in dental amalgam use. Notwithstanding improvements, lingering disparities persist among the most vulnerable population.

PRACTICAL IMPLICATIONS

Even within the groups identified as most vulnerable to harm, more targeted interventions and strategies are required to improve treatment among the most socially vulnerable.

摘要

背景

鉴于《水俣公约》对汞的关注以及逐步淘汰牙科汞合金使用的努力,追踪美国食品和药物管理局(FDA)确定的高危人群中牙科汞合金的使用比例,对于根据患者需求优化材料选择具有重要意义。

方法

对 Epic 的 Cosmos 电子健康记录数据集进行回顾性观察性研究,以计算 2017 年至 2023 年期间牙科汞合金修复的比例,并根据社会脆弱性指数(四分位数 4 表示最高社会脆弱性,四分位数 1 表示最低)和支付者类型(医疗保险、医疗补助、自付、杂项或其他)进行分层。作者纳入了以下 FDA 确定的高危人群:孕妇、6 岁以下儿童、有预先存在的神经系统疾病的人群以及肾功能受损的人群(n=1897976)。

结果

普通人群中牙科汞合金修复体的总体放置率从 2017 年的 21.8%下降到 2023 年的 4.1%。根据社会脆弱性指数四分位数和支付者类型,所有 4 个评估人群的牙科汞合金修复趋势均持续下降。在所有社会脆弱性指数四分位数中,代表最弱势群体的四分位数 4 在接受检查的 FDA 确定人群中,牙科汞合金放置率的下降幅度最小。

结论

研究结果表明,2017 年至 2023 年期间,FDA 确定的人群中牙科汞合金修复体的使用呈下降趋势,这与《水俣公约》逐步淘汰牙科汞合金使用的指令一致。尽管有所改善,但最脆弱人群中仍存在持续存在的差距。

实践意义

即使在被认为最容易受到伤害的人群中,也需要更有针对性的干预措施和策略,以改善最弱势群体的治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验